The prevalence of neuropathic pain: clinical evaluation compared with screening tools in a community population.
The prevalence of neuropathic pain: clinical evaluation compared with screening tools in a community population.
复制标题
DOI:
10.1111/j.1526-4637.2009.00588.x
复制
发表时间:
2009-04
期刊:
影响因子:
--
通讯作者:
Melton LJ 3rd
中科院分区:
文献类型:
--
作者:
Yawn BP;Wollan PC;Weingarten TN;Watson JC;Hooten WM;Melton LJ 3rd
Neuropathic pain is reported to be common based on studies from specialty centers and survey studies. However, few prevalence estimates have been completed in a community population using clinical evaluation. To develop an estimate of the prevalence of neuropathic pain in community dwelling adults. Data from a mailed survey (n=3575 community respondents), telephone interview (n=905), and a clinical examination (n=205) were linked to estimate the population prevalence of neuropathic pain. Using the clinical examination as the “gold” standard, estimates from several screening tools were developed and adjusted to the Olmsted County, Minnesota adult population. The estimated community prevalence of neuropathic pain from the clinical examination (gold standard) was 9.8%. Most other estimates were lower, including a 3.0% population prevalence using the Berger criteria and 8.8% using the S-LANSS. Only the prevalence rate based on self-report of nerve pain was higher (12.4%). Overlap among the groups each tool identified as having “neuropathic predominant pain” was only modest and the groups had significantly different rates of depressive symptoms, anxiety, limited functional ability and use of complementary and alternative medicine (CAM). The estimated rates and personal characteristics of community residents with “neuropathic pain” varies widely depending on the tools used to identify neuropathic pain. None of the screening tools compared well to clinical evaluation. The differences in the groups identified by alternative screening methods become of major importance when reporting neuropathic pain epidemiology, studying therapies for neuropathic pain or attempting to translate neuropathic pain research into clinical practice.
登录
查看更多内容
影响因子:
4
作者:
Berger, A;Dukes, EM;Oster, G
通讯作者:
Oster, G
影响因子:
2.4
作者:
Backonja, MM;Galer, BS
通讯作者:
Galer, BS
影响因子:
3.1
作者:
Watkins, Emmeline A.;Wollan, Peter C.;Yawn, Barbara P.
通讯作者:
Yawn, Barbara P.
影响因子:
2.3
作者:
Freynhagen, R;Baron, R;Maier, C
通讯作者:
Maier, C
影响因子:
3.4
作者:
STEER, RA;RISSMILLER, DJ;BECK, AT
通讯作者:
BECK, AT